Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial

In 2020, the American Society of Hematology published evidence-based guidelines for cerebrovascular disease in individuals with sickle cell anemia (SCA). Although the guidelines were based on National Institutes of Health–sponsored randomized controlled trials, no cost-effectiveness analysis was com...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Peter, Gay, James C., Lin, Chyongchiou J., Rodeghier, Mark, DeBaun, Michael R., Cronin, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153054/
https://www.ncbi.nlm.nih.gov/pubmed/34607344
http://dx.doi.org/10.1182/bloodadvances.2021004864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153054/
https://www.ncbi.nlm.nih.gov/pubmed/34607344
http://dx.doi.org/10.1182/bloodadvances.2021004864

Ejemplares similares